To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene RFT1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
160 supporting clones for gene RFT1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BP351053   .a 1 to 502 1 to 506   tiling clone,   506/552
(91 %)
16 diff
(97.2 %id)
DB444633 testis .a 11 to 442 1 to 431       431/431
(100 %)
4 diff
(99.1 %id)
NM_052859.3   .a 11 to 5106 1 to 5096 exact RefSeq, AAA   5096/5096
(100 %)
0 diff
(100 %id)
BC043595 Brain, fetal, whole pooled .a 18 to 2798 1 to 2781 exact tiling clone, available from MGC, AAA   2781/2781
(100 %)
3 diff
(99.9 %id)
BQ228283 brain .a 18 to 759 11 to 756       746/933
(79 %)
28 diff
(97.0 %id)
BQ924516 large cell carcinoma, lung .a 20 to 942 1 to 922       922/926
(99 %)
9 diff
(99.1 %id)
AL546604 placenta, Placenta Cot 25-normalized .a 24 to 998 1 to 971   fully sequenced,   971/971
(100 %)
20 diff
(98.0 %id)
BX363331   .a 24 to 872 1 to 848       848/848
(100 %)
11 diff
(98.8 %id)
BM546770 ovary (pool of 3) .a 25 to 804 1 to 781       781/1107
(70 %)
17 diff
(98.5 %id)
CR619807 Neuroblastoma Cot 25-normalized .a 26 to 1930 1 to 1905 exact     1905/1905
(100 %)
0 diff
(100 %id)
AJ318099 whole embryo .a 27 to 1945 1 to 1919 exact AAA   1919/1987
(96 %)
2 diff
(99.9 %id)
BG167718 hypernephroma, cell line, Kidney .a 27 to 544 1 to 518       518/518
(100 %)
0 diff
(100 %id)
BI819178 pooled brain, lung, testis .a 27 to 760 1 to 749       749/845
(88 %)
26 diff
(97.0 %id)
BI546668 brain, hippocampus .a 27 to 792 1 to 764       764/764
(100 %)
4 diff
(99.5 %id)
TI_57199571   .a 27 to 760 31 to 779       749/875
(85 %)
32 diff
(96.4 %id)
TI_44168684   .a 28 to 792 86 to 848       763/848
(89 %)
8 diff
(99.1 %id)
BX362181   .a 29 to 867 1 to 848       848/848
(100 %)
12 diff
(98.6 %id)
BE547151 cervical carcinoma cell line, cervix .a 31 to 622 1 to 594       594/1070
(55 %)
6 diff
(99.5 %id)
BM917080 blood, natural killer cells, cell line .a 34 to 621 1 to 593       593/1042
(56 %)
16 diff
(98.5 %id)
BQ057772 lymph, lymphoma, cell line .a 41 to 877 1 to 847       845/1045
(80 %)
15 diff
(98.6 %id)
BQ642245 lymph, lymphoma, cell line .a 41 to 770 1 to 730       730/958
(76 %)
10 diff
(99.0 %id)
DN997322 breast cancer, Mammary gland (cancer tissue) .a 43 to 430 1 to 388       388/388
(100 %)
11 diff
(97.2 %id)
AL524824 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 48 to 1030 21 to 1002   fully sequenced,   982/1002
(98 %)
14 diff
(98.7 %id)
AL547085 placenta, Placenta Cot 25-normalized .a 51 to 1022 1 to 968       968/968
(100 %)
9 diff
(99.1 %id)
BM926007 brain .a 53 to 891 6 to 846       841/1083
(77 %)
9 diff
(99.2 %id)
BX341182   .a 55 to 888 1 to 836       836/836
(100 %)
8 diff
(99.1 %id)
CN398348 embryonic stem cells, cell lines H1, H7, andH9 .a 59 to 651 11 to 603       593/603
(98 %)
6 diff
(99.1 %id)
BQ439611 epithelioid carcinoma, Pancreas .a 60 to 900 47 to 887       839/911
(92 %)
24 diff
(97.4 %id)
CD635318   .a 557 to 1138 8 to 589       582/589
(98 %)
6 diff
(99.0 %id)
BI868185 adenocarcinoma, cell line, Liver .a 605 to 1438 13 to 850       838/851
(98 %)
20 diff
(97.7 %id)
TI_57227838   .a 605 to 1438 66 to 903       838/851
(98 %)
20 diff
(97.7 %id)
BG027544 Bone, osteosarcoma, cell line .a 685 to 1406 1 to 729       729/863
(84 %)
6 diff
(99.4 %id)
BE899398 adenocarcinoma cell line, ovary .a 730 to 1506 29 to 789       761/1003
(75 %)
26 diff
(97.5 %id)
BE742666 adenocarcinoma cell line, ovary .a 749 to 1484 1 to 732       732/733
(99 %)
7 diff
(99.1 %id)
BF352604 head_neck .a 805 to 1344 553 to 13       541/571
(94 %)
5 diff
(99.2 %id)
BG251005 adenocarcinoma, cell line, Liver .a 815 to 1524 1 to 708       708/956
(74 %)
7 diff
(99.3 %id)
CF618862 Pooled Chondrosarcoma Tumor cells .a 845 to 1414 38 to 616       579/1084
(53 %)
23 diff
(97.9 %id)
CF618861 Pooled Chondrosarcoma Tumor cells .a 855 to 1504 9 to 668       660/958
(68 %)
29 diff
(97.0 %id)
BG752422 eye, normal pigmented retinal epithelium .a 906 to 1683 1 to 784       784/814
(96 %)
13 diff
(98.5 %id)
BM799040 Ascites, stomach .a 918 to 1342 1 to 425       425/425
(100 %)
4 diff
(99.1 %id)
CN398349 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 930 to 1522 1 to 593       593/593
(100 %)
0 diff
(100 %id)
BE880241 large cell carcinoma, undifferentiated, lung .a 949 to 1728 1 to 764       764/1004
(76 %)
24 diff
(97.7 %id)
BE903838 epithelioid carcinoma, Pancreas .a 963 to 1706 1 to 733       733/893
(82 %)
14 diff
(98.5 %id)
AL571991 placenta, Placenta Cot 25-normalized .a 970 to 1883 902 to 1   fully sequenced,   902/902
(100 %)
17 diff
(98.2 %id)
AL524823 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 991 to 1930 934 to 1   fully sequenced,   934/934
(100 %)
9 diff
(99.1 %id)
CD635319   .a 1009 to 1749 749 to 14       736/749
(98 %)
14 diff
(98.2 %id)
BF033804 adenocarcinoma, ovary .a 1013 to 1683 1 to 677       677/736
(91 %)
7 diff
(99.1 %id)
BE544869 cervical carcinoma cell line, cervix .a 1019 to 1626 7 to 611       605/611
(99 %)
4 diff
(99.4 %id)
BX402281 Placenta Cot 25-normalized .a 1020 to 1921 902 to 1       902/1002
(90 %)
23 diff
(97.8 %id)
AL572173 placenta, Placenta Cot 25-normalized .a 1022 to 2033 998 to 1       998/998
(100 %)
16 diff
(98.4 %id)
CB120033 Liver .a 1028 to 1254 1 to 227       227/227
(100 %)
2 diff
(99.2 %id)
BX377911 Placenta Cot 25-normalized .a 1033 to 1872 838 to 1       838/842
(99 %)
15 diff
(98.3 %id)
CN398350 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1047 to 1477 1 to 431       431/431
(100 %)
1 diff
(99.8 %id)
BX342276   .a 1055 to 1915 868 to 1       868/872
(99 %)
13 diff
(98.6 %id)
DA759482   .a 1083 to 1514 2 to 433   capped   432/432
(100 %)
1 diff
(99.8 %id)
BE697836 colon .a 1097 to 1463 1 to 366       366/366
(100 %)
10 diff
(97.3 %id)
BC006846 Placenta, choriocarcinoma .a 1097 to 1943 1 to 847   available from MGC, AAA   847/847
(100 %)
0 diff
(100 %id)
BE536833 cervix .a 1119 to 1876 1 to 751   available from MGC,   751/827
(90 %)
22 diff
(97.4 %id)
BM826909 Ascites, stomach .a 1138 to 1492 1 to 355       355/355
(100 %)
0 diff
(100 %id)
CD635320   .a 1142 to 1477 352 to 18       335/354
(94 %)
1 diff
(99.8 %id)
CD635321   .a 1150 to 1477 1 to 328       328/346
(94 %)
2 diff
(99.5 %id)
AW376337 colon .a 1160 to 1321 60 to 221       162/221
(73 %)
6 diff
(97.3 %id)
BX329951 Placenta Cot 25-normalized .a 1166 to 1917 768 to 10       759/931
(81 %)
21 diff
(97.8 %id)
BM193177 leukopheresis .a 1168 to 1436 1 to 269       269/269
(100 %)
10 diff
(96.3 %id)
BU616987 Cell Line, Chondrosarcoma .a 1250 to 1940 707 to 17   AAA   691/691
(100 %)
0 diff
(100 %id)
CA430605 Cell Line, Chondrosarcoma .a 1250 to 1940 707 to 17   AAA   691/691
(100 %)
0 diff
(100 %id)
BF475369 Prostate .a 1271 to 1943 672 to 1       672/676
(99 %)
11 diff
(98.4 %id)
BU626250 cell lines, Enchondroma .a 1277 to 1937 678 to 19   AAA   660/678
(97 %)
3 diff
(99.6 %id)
DA720048   .a 1279 to 1861 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DA234371 brain .a 1280 to 1801 2 to 523   capped   522/522
(100 %)
1 diff
(99.9 %id)
DA781375 brain .a 1281 to 1856 2 to 578   capped   577/577
(100 %)
3 diff
(99.5 %id)
DA403532 thalamus .a 1285 to 1743 2 to 460   capped   459/459
(100 %)
1 diff
(99.8 %id)
BX373970   .a 1291 to 1930 639 to 1       639/660
(96 %)
28 diff
(95.8 %id)
AW169270 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1297 to 1943 662 to 17   AAA   646/646
(100 %)
12 diff
(98.2 %id)
BE903984 epithelioid carcinoma, Pancreas .a 1336 to 1944 1 to 606       606/608
(99 %)
7 diff
(98.9 %id)
BQ001063 lung, Metastatic Chondrosarcoma .a 1366 to 1943 596 to 19   AAA   578/579
(99 %)
4 diff
(99.4 %id)
BU620480 cell lines, Chondrosarcoma .a 1371 to 1938 586 to 19   AAA   568/568
(100 %)
2 diff
(99.7 %id)
BE881512 large cell carcinoma, undifferentiated, lung .a 1378 to 1933 1 to 555       555/555
(100 %)
1 diff
(99.9 %id)
BG230736 blood, lymphocyte .a 1394 to 1945 553 to 2       552/553
(99 %)
0 diff
(100 %id)
BQ001156 lung, Metastatic Chondrosarcoma .a 1445 to 1943 517 to 19   AAA   499/499
(100 %)
3 diff
(99.4 %id)
AA716162 heart .a 1446 to 1945 500 to 1       500/500
(100 %)
1 diff
(99.8 %id)
AW183635 pooled .a 1453 to 1939 489 to 3       487/489
(99 %)
1 diff
(99.8 %id)
AI141766 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1456 to 1939 483 to 1       483/483
(100 %)
4 diff
(99.2 %id)
BM999725 lung, Lung Focal Fibrosis .a 1459 to 1943 503 to 19   AAA   485/485
(100 %)
1 diff
(99.8 %id)
AI188277 placenta .a 1462 to 1943 482 to 1       482/482
(100 %)
1 diff
(99.8 %id)
BQ005995 Chondrosarcoma, Left Pelvis .a 1469 to 2062 610 to 17   AAA   594/594
(100 %)
3 diff
(99.5 %id)
AI624087 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1470 to 1943 473 to 1       473/473
(100 %)
3 diff
(99.4 %id)
AW173452 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 1478 to 1945 471 to 4       468/471
(99 %)
0 diff
(100 %id)
AI129419 uterus .a 1485 to 1937 465 to 13   AAA   453/453
(100 %)
2 diff
(99.6 %id)
BX477000   .a 1489 to 2112 1 to 622       622/622
(100 %)
5 diff
(99.2 %id)
AI828817 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1494 to 1943 450 to 1       450/450
(100 %)
2 diff
(99.6 %id)
AI683124 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1494 to 1943 450 to 1       450/450
(100 %)
1 diff
(99.8 %id)
AI308087 2 pooled tumors (clear cell type), Kidney .a 1502 to 1934 438 to 6       433/438
(98 %)
0 diff
(100 %id)
BX109975 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1513 to 1943 445 to 15   AAA   431/431
(100 %)
2 diff
(99.6 %id)
DB509550 testis .a 1517 to 1928 1 to 421     Submitted on the opposite strand 421/421
(100 %)
9 diff
(97.9 %id)
BF061917 pooled germ cell tumors .a 1544 to 1945 406 to 5       402/406
(99 %)
0 diff
(100 %id)
AA701470 liver and spleen .a 1550 to 1913 364 to 1       364/364
(100 %)
0 diff
(100 %id)
AW471490 colon, moderately-differentiated adenocarcinoma .a 1558 to 1943 386 to 1       386/386
(100 %)
1 diff
(99.8 %id)
AW291854   .a 1560 to 1938 395 to 18   AAA   378/378
(100 %)
2 diff
(99.5 %id)
AW615124 pooled germ cell tumors .a 1575 to 1945 375 to 5       371/375
(98 %)
0 diff
(100 %id)
AA315210 lung .a 1594 to 1895 1 to 303       303/306
(99 %)
6 diff
(98.1 %id)
BF447518 sympathetic trunk .a 1600 to 1944 345 to 1       345/345
(100 %)
0 diff
(100 %id)
AW025680 pooled germ cell tumors .a 1616 to 1945 334 to 5       330/334
(98 %)
0 diff
(100 %id)
CB048486 Prostate .a 1633 to 1944 10 to 321   fully sequenced, AAA   312/321
(97 %)
6 diff
(98.2 %id)
AW449210   .a 1647 to 1933 304 to 18   AAA   287/297
(96 %)
0 diff
(100 %id)
AI239598 pooled .a 1662 to 1934 275 to 3       273/275
(99 %)
0 diff
(100 %id)
AW504333 lymph .a 1663 to 2019 1 to 357       357/357
(100 %)
4 diff
(98.9 %id)
TI_154160476   .a 1670 to 2208 86 to 624   tiling clone,   539/542
(99 %)
20 diff
(96.4 %id)
CB048485 Prostate .a 1673 to 1943 293 to 24   fully sequenced, AAA   270/270
(100 %)
2 diff
(99.3 %id)
BX476897   .a 1688 to 2044 1 to 357       357/357
(100 %)
1 diff
(99.8 %id)
AI284846 ovary, tumor, 5 pooled (see description) .a 1715 to 2063 349 to 1       349/349
(100 %)
0 diff
(100 %id)
AI355748 lung .a 1717 to 2091 377 to 3       375/377
(99 %)
0 diff
(100 %id)
AW194025 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1835 to 2091 259 to 3       257/259
(99 %)
0 diff
(100 %id)
AI565340 Kidney .a 1853 to 2173 322 to 1       322/322
(100 %)
3 diff
(99.1 %id)
TI_45235900   .a 2055 to 2728 683 to 1       683/936
(72 %)
23 diff
(97.6 %id)
BI518088 pooled colon, kidney, stomach .a 2060 to 2728 678 to 1       678/678
(100 %)
20 diff
(97.1 %id)
TI_154197535   .a 2070 to 2789 81 to 796       716/921
(77 %)
28 diff
(97.0 %id)
AI823608 2 pooled tumors (clear cell type), Kidney .a 2092 to 2554 465 to 3       463/465
(99 %)
0 diff
(100 %id)
AW803123 uterus .a 2098 to 2543 23 to 469   tiling clone,   447/472
(94 %)
3 diff
(99.4 %id)
TI_154195903   .a 2158 to 2685 102 to 630       529/1088
(48 %)
6 diff
(99.5 %id)
AI282106 2 pooled tumors (clear cell type), Kidney .a 2237 to 2604 385 to 18   AAA   368/368
(100 %)
0 diff
(100 %id)
BG991641 head_neck .a 2602 to 3005 405 to 1   tiling clone,   405/405
(100 %)
0 diff
(100 %id)
AK098811 thyroid .a 2819 to 5106 1 to 2288   tiling clone, available from FLJ,   2288/2288
(100 %)
7 diff
(99.7 %id)
BF834123 head_neck .a 2829 to 3370 554 to 13     Submitted on the opposite strand 542/554
(97 %)
0 diff
(100 %id)
AL713685 lymph node .a 2872 to 5106 1 to 2235   tiling clone, available from DKFZ, AAA   2235/2235
(100 %)
4 diff
(99.9 %id)
CV368086 colon .a 2874 to 3338 468 to 1     Submitted on the opposite strand 468/473
(98 %)
23 diff
(95.2 %id)
H30238 brain .a 2879 to 3285 1 to 408       408/408
(100 %)
1 diff
(99.8 %id)
BE147826 head_neck .a 2896 to 3357 1 to 460       460/460
(100 %)
8 diff
(98.3 %id)
BF830636 head_neck .a 2910 to 3368 468 to 10     Submitted on the opposite strand 459/468
(98 %)
0 diff
(100 %id)
AW814009 stomach .a 2922 to 3338 1 to 419       419/419
(100 %)
4 diff
(99.1 %id)
CV420312 colon .a 2938 to 3376 440 to 1     Submitted on the opposite strand 440/440
(100 %)
9 diff
(98.0 %id)
BC101249 PCR rescued clones .a 2946 to 3919 1 to 974       974/974
(100 %)
0 diff
(100 %id)
BC113058 PCR rescued clones .a 2946 to 3919 1 to 974       974/974
(100 %)
0 diff
(100 %id)
BC113059 PCR rescued clones .a 2946 to 3919 1 to 974       974/974
(100 %)
0 diff
(100 %id)
BC101247 PCR rescued clones .a 2946 to 3920 1 to 975       975/975
(100 %)
0 diff
(100 %id)
BC101248 PCR rescued clones .a 2946 to 3920 1 to 975       975/975
(100 %)
0 diff
(100 %id)
BC101250 PCR rescued clones .a 2946 to 3920 1 to 975       975/975
(100 %)
0 diff
(100 %id)
DA262077 caudate nucleus .a 2989 to 3508 2 to 521   capped   520/520
(100 %)
0 diff
(100 %id)
CA396781 eye, RPE/choroid .a 3068 to 3497 1 to 430       430/430
(100 %)
1 diff
(99.8 %id)
AW968523   .a 3173 to 3811 1 to 641       641/641
(100 %)
3 diff
(99.6 %id)
AA485174 germinal center B cell .a 3186 to 3506 1 to 322       322/322
(100 %)
2 diff
(99.4 %id)
TI_154002914   .a 3226 to 3884 85 to 746     Submitted on the opposite strand 662/1159
(57 %)
37 diff
(96.9 %id)
BE779073 eye, retinoblastoma .a 3238 to 3832 1 to 594       594/598
(99 %)
8 diff
(98.7 %id)
BF857843 prostate_tumor .a 4097 to 4546 15 to 462       448/467
(95 %)
6 diff
(98.8 %id)
BF857846 prostate_tumor .a 4104 to 4546 24 to 465   tiling clone,   442/470
(94 %)
6 diff
(98.8 %id)
DB306723 caudate nucleus .a 4561 to 5099 540 to 1   tiling clone,   540/540
(100 %)
2 diff
(99.7 %id)
DB326257 brain .a 4563 to 5099 538 to 1       538/538
(100 %)
4 diff
(99.3 %id)
H26983 brain .a 4691 to 5097 414 to 1       414/421
(98 %)
10 diff
(97.7 %id)
AI680333 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 4727 to 5105 379 to 1       379/379
(100 %)
0 diff
(100 %id)
CR613853 Placenta Cot 25-normalized .b 1 to 1800 1 to 1800 exact tiling clone,   1800/1800
(100 %)
0 diff
(100 %id)
BX402282 Placenta Cot 25-normalized .b 13 to 1018 1 to 991       991/1008
(98 %)
34 diff
(96.7 %id)
BX396167 Placenta Cot 25-normalized .b 18 to 1023 23 to 1026       1002/1026
(97 %)
13 diff
(98.8 %id)
BE559585 Burkitt lymphoma, lymph .b 35 to 763 1 to 725       725/831
(87 %)
33 diff
(96.1 %id)
CR605993 Neuroblastoma Cot 50-normalized .b 115 to 1751 1 to 1637       1637/1637
(100 %)
0 diff
(100 %id)
AL530692 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .b 115 to 846 1 to 732   fully sequenced,   732/732
(100 %)
13 diff
(98.3 %id)
AL530691 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .b 816 to 1751 927 to 1   fully sequenced,   927/927
(100 %)
28 diff
(97.0 %id)
BU528699 epidermoid carcinoma, cell line, lung .c 1 to 886 1 to 889 A262L K263L V264R L265C E266W ... tiling clone,   889/889
(100 %)
5 diff
(99.5 %id)
BE313520 brain, neuroblastoma .d 1 to 621 1 to 617   tiling clone,   617/636
(97 %)
20 diff
(96.9 %id)
BU788149 insulinoma, Pancreas .d 437 to 693 1 to 257   tiling clone,   257/257
(100 %)
6 diff
(97.7 %id)
BX370310   .e 1 to 914 7 to 920 F2L Y3F T4L T5P V6S ... tiling clone,   923/928
(99 %)
29 diff
(96.9 %id)
BX642406   .f-u 1 to 629 1 to 629   tiling clone,   629/629
(100 %)
1 diff
(99.9 %id)
BF094269 uterus_tumor .f-u 481 to 856 387 to 13   tiling clone,   375/387
(96 %)
0 diff
(100 %id)
BX642407   .f-u 3374 to 4095 723 to 1   tiling clone,   723/723
(100 %)
3 diff
(99.6 %id)
BX107241 pooled .g-u 1 to 463 1 to 463 R75K tiling clone,   463/465
(99 %)
3 diff
(99.4 %id)
AI742522 pooled .g-u 171 to 664 504 to 11   AAA   494/494
(100 %)
3 diff
(99.4 %id)
AI873201 pooled .g-u 261 to 667 410 to 1       410/411
(99 %)
3 diff
(99.3 %id)
AI568579 anaplastic oligodendroglioma, brain .g-u 267 to 666 400 to 1       400/400
(100 %)
0 diff
(100 %id)
AA724082 pooled .g-u 275 to 668 394 to 1   tiling clone,   394/394
(100 %)
0 diff
(100 %id)
BG012212 placenta_normal .h-u 1 to 474 477 to 2 exact tiling clone,   476/477
(99 %)
0 diff
(100 %id)
BF909541 uterus_tumor .i-u 1 to 266 18 to 283 M30K tiling clone,   266/301
(88 %)
3 diff
(99.1 %id)
AW968699   Gene RFT1, variant not shown         Submitted on the opposite strand    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g-u, .h-u, .i-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC